LONG-TERM EFFICACY AND SAFETY OF UPADACITINIB IN PATIENTS WITH PSORIATIC ARTHRITIS REFRACTORY TO BIOLOGIC THERAPIES: 2-YEAR RESULTS FROM THE PHASE 3 SELECT-PSA 2 STUDY

被引：2

作者：

Mease, P. J. ^{[1
,2
]}

Setty, A. ^{[3
]}

Papp, K. ^{[4
]}

Van den Bosch, F. ^{[5
]}

Tsuji, S. ^{[6
]}

Keiserman, M. ^{[7
]}

Bu, X. ^{[3
]}

Chen, L. ^{[3
]}

Mccaskill, R. ^{[3
]}

Mcdearmon-Blondell, E. ^{[3
]}

Wung, P. ^{[3
]}

Tillett, W. ^{[8
]}

机构：

[1] Providence St Joseph Hlth, Swedish Med Ctr, Seattle, WA USA

[2] Univ Washington, Rheumatol, Seattle, WA 98195 USA

[3] AbbVie Inc, Immunol, N Chicago, IL USA

[4] Papp Clin Res & Prob Med Res, Dermatol, Waterloo, ON, Canada

[5] Univ Ghent, VIB Ctr Inflammat Res, Internal Med & Pediat, Ghent, Belgium

[6] Natl Hosp Org, Osaka Minami Med Ctr, Orthopaed Rheumatol, Osaka, Japan

[7] Pontifical Catholic Univ, Sch Med, Rheumatol, Porto Alegre, RS, Brazil

[8] Royal Natl Hosp Rheumat Dis, Rheumatol, Bath, Avon, England

来源：

ANNALS OF THE RHEUMATIC DISEASES | 2022年 / 81卷

关键词：

D O I：

10.1136/annrheumdis-2022-eular.1897

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

POS1041

引用

页码：836 / 837

页数：2

共 1 条

[1] Upadacitinib in Patients with Psoriatic Arthritis and Inadequate Response to Biologics: 56-Week Data from the Randomized Controlled Phase 3 SELECT-PsA 2 Study [J].

Mease, Philip J. ;

Lertratanakul, Apinya ;

Papp, Kim A. ;

van den Bosch, Filip E. ;

Tsuji, Shigeyoshi ;

Dokoupilova, Eva ;

Keiserman, Mauro W. ;

Bu, Xianwei ;

Chen, Liang ;

McCaskill, Reva M. ;

Zueger, Patrick ;

McDearmon-Blondell, Erin L. ;

Pangan, Aileen L. ;

Tillett, William .

RHEUMATOLOGY AND THERAPY, 2021, 8 (02) :903-919

← 1 →